IMMUNOTHERAPY

18/06/2025 10:45 20:00

Poster and Exhibition Hall

Time	Session

10:45 20:00	Nanobodies against PSMA as the foundation for new tracers for prostate cancer imaging and treatment P-495 EACR25-0109 Tong Yang Poster Presenter Netherlands	Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation P-497 EACR25-0203 Hong Seok Kim Poster Presenter Korea (Republic of)	Exercise to boost the immune system and optimise immunotherapy responsiveness in pancreatic cancer P-498 EACR25-0279 Brindley Hapuarachi Poster Presenter United Kingdom	Epigenetic Modulation of CAR-T cells against Group 3 Medulloblastoma P-499 EACR25-0289 Song San Chan Poster Presenter United Kingdom	Unveiling interactions between senescent tumor cells and the host immune system - Implications for Senolytic Immunotherapy P-500 EACR25-0347 Bartolomeo Bosco Poster Presenter Germany	Investigating the repurposing potential of immune checkpoint inhibitors to additional cancer patient populations using Mendelian randomisation P-501 EACR25-0435 Tessa Bate Poster Presenter United Kingdom	Assessing the Potential of Epigenetic Inhibitors to Improve Immunotherapy Response via In Vitro Models P-502 EACR25-0481 Manuel Pino Gonz Poster Presenter Spain	Bacterial Endospores as Antigen Carriers: A Novel Strategy for Cancer Vaccines P-901 EACR25-0671 Lourenço Cayolla Bonneville Poster Presenter Italy	Next Generation Protein Characterization of CD19-CAR Signaling Cascades P-503 EACR25-0825 Warren Higgs Poster Presenter United Kingdom	The effect of STING agonist on lung metastases and immune landscape in murine model of spontaneous breast cancer metastasis P-504 EACR25-0955 Alina Drzyzga Poster Presenter Poland	Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform P-505 EACR25-1001 Paola Genevini Poster Presenter Italy	Understanding bystander killing by bispecific monoclonal antibodies P-506 EACR25-1143 May Sin Ke Poster Presenter United Kingdom	A novel synthetic peptide HS1002 Enhances T Cell-Mediated Antitumor Immunity P-507 EACR25-1203 Jae Hyeon Park Poster Presenter Korea (Republic of)	Induction of TWIST1-specific antitumor immunity by DNA vaccine encoding a truncated TWIST1 antigen P-508 EACR25-1425 Zhiwu Tan Poster Presenter Hong Kong, China	mRNA Cancer Vaccines: Leveraging Sugar-Functionalized LNPs for Targeted Antitumor Immunity P-509 EACR25-1491 Jo Poster Presenter Portugal	Characterization of radiolabelled single-domain anti-HER2 antibodies as potential radioimmunotherapeutics for breast cancer P-510 EACR25-1577 Zuzanna Napora Poster Presenter Poland	Glycopolymer-Mediated Gene Delivery for Efficient CAR-T Cell Production P-511 EACR25-1641 Diana Pinheiro Correia Poster Presenter Portugal	Cellular Composition and Dynamics Upon Immunotherapy Correlate with Clinical Response P-512 EACR25-1649 Zhongyang Lin Poster Presenter Israel	Redox-Responsive Self-Immolative Nanogels for Cellular Immunotherapies P-513 EACR25-1671 Diana Pinheiro Correia Poster Presenter Portugal	Development of PD-L1 based cancer vaccine conjugating a novel T cell epitope P-514 EACR25-1699 Tomoyuki Nishikawa Poster Presenter Japan	Selection and identification of nanobodies against a cancer-testis antigen, placenta-specific protein 1 P-515 EACR25-1757 Phakjira Tiraratchailert Poster Presenter Thailand	Patient-derived tumor tissue cultures (PDTTCs) as a new platform for assessing T cell engager efficacy in glioblastoma. P-516 EACR25-1815 Raffaella Iurlaro Poster Presenter Spain	ENO3PEP vaccine enhances chemotherapy efficacy in pancreatic cancer by boosting anti-tumor immunity P-517 EACR25-1817 Silvia Brugiapaglia Poster Presenter Italy	Enhanced natural killer cell anti-tumor activity with Erastin mediated ferroptosis and potential therapeutic application in neuroblastoma. P-518 EACR25-1823 Ganesh Umapathy Poster Presenter Sweden	An innovative immune-on-chip platform for studying tumor-immune interactions and evaluating novel immunomodulatory therapies P-519 EACR25-1849 SILVIA SCAGLIONE Poster Presenter	MicroRNAs humoral and cellular immune response profile to COVID-19 vaccine boost in cancer patients P-907 EACR25-1881 Tânia Rôlo Dias Poster Presenter Portugal	The immune and metabolic profile in metastatic and early-stage triple negative breast cancer patients treated with immune checkpoint inhibitors. P-520 EACR25-1935 Luc Poster Presenter Spain	Exploring CAR-T Cell Killing Dynamics Through Live-Cell Fluorescence Microscopy P-521 EACR25-1965 Svenja Meiler Poster Presenter	Characterization of Different CAR Architectures Harboring the Murine GD2 Binder 14G2a P-521A EACR25-1987 Ines del Rincon Poster Presenter Germany	Cytotoxic ILC-1 cells determine outcome of PD-(L)1 blockade in microsatellite instable cancers P-522 EACR25-2039 Paula Van Royen Poster Presenter Netherlands	Visualization and quantification of antibody-dependent cellular phagocytosis (ADCP) using a live-cell imaging high-throughput automation system P-523 EACR25-2051 Reinhild Geisen Poster Presenter Germany	Distinct chemotherapy regimens differentially modulate the immune landscape of triple-negative breast cancer, with potential impact on combination with immunotherapy P-524 EACR25-2225 Marco Barreca Poster Presenter Italy	Inhibition of Furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities P-525 EACR25-2299 Lydia Ziane Chaouche Poster Presenter France	A positive crosstalk between chemokine receptor CXCR4 and intrinsic programmed cell death-1 receptor (iPD-1): anti PD-1, nivolumab, impairs CXCL12-induced signaling, proliferation and migration in human colon cancer cells P-526 EACR25-2311 Caterina Ieran Poster Presenter Italy	Combining NK/CAR-NK-based therapy with autophagy inhibition as therapeutic strategy in high-risk medulloblastoma P-527 EACR25-2321 Manuela Giansanti Poster Presenter Italy	Anti-IL-7Rα antibodies: a targeted therapy for T-cell Acute Lymphoblastic Leukemia P-528 EACR25-2349 Mafalda Dias Duque Poster Presenter Portugal	Improving Triple-Negative Breast Cancer immunogenicity via viral-mediated epigenetic remodeling P-529 EACR25-2457 Salvatore Russo Poster Presenter Finland	Advancing CAR-T clinical development with high-parameter CyTOF technology P-530 EACR25-2549 Melissa Klug Poster Presenter